Abstract
Midodrine hydrochloride is a potent peripherally-acting α1 agonist that is well absorbed and rapidly metabolized to its active metabolite. It has been used for the treatment of refractory syncope but has the important side effect of supine hypertension. A 10-year-old boy with severe symptomatic orthostatic hypotension was treated with midodrine. After therapy, syncope attacks ceased but he suffered nighttime headaches, nausea, transient rash and itchy/prickly scalp. Midodrine was discontinued when supine hypertension was noticed. However, his supine hypertension continued until day 19 after discontinuation. This case shows that patients receiving midodrine should be observed for supine hypertension for a prolonged period.
Similar content being viewed by others
References
McEvoy GK (2004) Midodrine Hydrochloride. American Hospital Formulary Service Drug Information. American Society of Health-System Pharmacists, Bethesda, MD
Roberts Pharmaceutical Corporation (1998) ProAmatine (midodrine hydrochloride) tablets prescribing information (dated 1996 Sep). In: Physicians’ Desk Reference 1998. Medical Economics, Montvale, NJ, pp 2408–2410
Weippl G (1979) Infectious toxic hypotension—effect and dosage of midodrine [Author’s translation]. Padiatr Padol 14:211–216
Zachariah PK, Bloedow DC, Moyer TP, et al. (1986) Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther 39:586–591
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olgar, S., Omeroglu, R. Prolonged Supine Hypertension Due to Midodrine Use in an Orthostatic Hypotensive Child. Pediatr Cardiol 28, 309–310 (2007). https://doi.org/10.1007/s00246-006-0169-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-006-0169-y